» Articles » PMID: 19915137

Alternative Mouse Models for Carcinogenicity Assessment: Industry Use and Issues with Pathology Interpretation

Overview
Journal Toxicol Pathol
Publisher Sage Publications
Date 2009 Nov 17
PMID 19915137
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The Carcinogenicity Alternative Mouse Models (CAMM) Working Group of the Society of Toxicologic Pathology (STP) surveyed the membership to define current practices and opinions in industry regarding the use of alternative mouse models for carcinogenicity testing. The results of the survey indicated that CAMM are used most often to fulfill a regulatory requirement (e.g., to replace the two-year mouse bioassay) and are being accepted by regulatory agencies. Alternative models are also sometimes used for internal decision making or to address a mechanistic question. The CAMM most commonly used are the p53+/- and rasH2. The rasH2 appears to be the currently accepted model for general carcinogenicity testing. Problems with study interpretation included lack of historic background data, unexpected tumor finding, and tumor identification/characterization of early lesions. Problems with implementation or conduct of the study included extent of the pathology evaluation, numbers of animals, survival, and study duration. Recommendations were developed for, frequency and type of positive control testing, extent of histopathologic examination of test article-treated and positive control animals, current use and future development of diagnostic criteria; increased availability and use of historic data, and use of other genetically modified mice in carcinogenicity testing.

Citing Articles

Short-term carcinogenicity study of N-methyl-N-nitrosourea in FVB-Trp53 heterozygous mice.

Kim N, Seo S, Yoo E, Kang A, Lee J, Lee J PLoS One. 2023; 18(1):e0280214.

PMID: 36608059 PMC: 9821506. DOI: 10.1371/journal.pone.0280214.


rasH2 mouse: reproducibility and stability of carcinogenicity due to a standardized production and monitoring system.

Tsutsumi H, Inoue R, Yasuda M, Takahashi R, Suzuki M, Urano K J Toxicol Pathol. 2022; 35(1):19-24.

PMID: 35221492 PMC: 8828604. DOI: 10.1293/tox.2021-0068.


Organ accumulation and carcinogenicity of highly dispersed multi-walled carbon nanotubes administered intravenously in transgenic rasH2 mice.

Sobajima A, Haniu H, Nomura H, Tanaka M, Takizawa T, Kamanaka T Int J Nanomedicine. 2019; 14:6465-6480.

PMID: 31616140 PMC: 6698589. DOI: 10.2147/IJN.S208129.


Immunohistochemical characterization of urethane-induced lung tumors in CB6F1-Tg rasH2 mice.

Sano T, Watanabe T, Ishimura Y, Anayama H J Toxicol Pathol. 2017; 30(2):177-181.

PMID: 28458456 PMC: 5406597. DOI: 10.1293/tox.2016-0066.


Defining the toxicology of aging.

Sorrentino J, Sanoff H, Sharpless N Trends Mol Med. 2014; 20(7):375-84.

PMID: 24880613 PMC: 4082749. DOI: 10.1016/j.molmed.2014.04.004.